RSS   Newsletter   Contact   Advertise with us
Post Online Media

PureTech Health names chief scientific officer

PureTech HealthPureTech Health, a healthcare company, announced the appointment of Joseph Bolen as the company’s chief scientific officer.
Article continues below

READ MORE PureTech Health appoints Michael MacLean as CFO, EVP

Mr. Bolen brings to PureTech decades of industry experience in immunology and oncology, having overseen the discovery and advancement of more than 30 drugs into clinical development.

Mr. Bolen most recently oversaw all aspects of research and development for Moderna Therapeutics as President and Chief Scientific Officer.

Previously, Mr. Bolen was Chief Scientific Officer and Global Head of Oncology Research at Millennium: The Takeda Oncology Company.

He held senior R&D positions at Hoechst Marion Roussel, Schering-Plough (DNAX), and Bristol-Myers Squibb. He began his career at the NIH, where he contributed to the discovery of a class of proteins.

Dr. Bolen graduated from the University of Nebraska with a B.S. degree in Microbiology & Chemistry and a Ph.D. in Immunology and conducted his postdoctoral training in Molecular Virology at the Kansas State University Cancer Center.

 LATEST MOVES FROM Massachusetts 


 
 

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy